Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!
( discontinuation ) with medication was calculated after 18 and 36 months.ResultsIndividuals older than 53 years were more adherent to LLT (MPR > 80%) than those younger than 36 years (odds ratio [(OR] 1.30, p ...
after switching of LLDs were also analysed. Results Discontinuation /switching of lipid ‐ lowering therapy was common during the study period, especially among patients who received nonstatin, nonfibrate ...
, discontinuation or initiation of antihypertensive and lipid - lowering therapy after bariatric surgery compared with those in a matched control group of obese patients. Methods This nationwide observational ...
compare patterns of lipid - lowering treatment before and 1 year after the release of the 2013 cholesterol guideline in 2 high-risk groups: patients with ASCVD and patients with diabetes ...
with rosiglitazone.Discussion:Thiazolidinediones, insulin sensitizers widely used in the treatment of type 2 diabetes , have been reported to have beneficial effects on lipids , such as triglyceride lowering and HDL-C elevation, in addition ...
of achieving the treatment goal were LDL-C values at the start of lipid - lowering therapy and their reduction after six months. Other predictors of a greater likelihood of reaching the target included high ...
, hyperlipidemia, diabetes mellitus), but were attenuated towards unity with increasingly larger covariate sets used for confounding control. We found that after IPTW adjustment the generic formulation ...
results can be negatively affected in "real life" clinical practice by an important issue: compliance. No medications will work if patients do not take them. Unfortunately, patients who need lipid - lowering ...
additional prescriptions for a lipid - lowering drug after filling the prescription on their index date, and 34.1% and 38.9% of patients had medication available during 80% or more of the year. The most commonly ...
and lipid profiles. The reported case is a 35-year-old man with obesity, dyslipidemia, and T2D for 5 years. Despite the use of five antidiabetic medications , including insulin, HbA1c was 10.1%. A VLCKD ...
Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!